Identification of specific gene copy number changes in asbestos-related lung cancer
- PMID: 16740712
- DOI: 10.1158/0008-5472.CAN-06-0199
Identification of specific gene copy number changes in asbestos-related lung cancer
Abstract
Asbestos is a well-known lung cancer-causing mineral fiber. In vitro and in vivo experiments have shown that asbestos can cause chromosomal damage and aberrations. Lung tumors, in general, have several recurrently amplified and deleted chromosomal regions. To investigate whether a distinct chromosomal aberration profile could be detected in the lung tumors of heavily asbestos-exposed patients, we analyzed the copy number profiles of 14 lung tumors from highly asbestos-exposed patients and 14 matched tumors from nonexposed patients using classic comparative genomic hybridization (CGH). A specific profile could lead to identification of the underlying genes that may act as mediators of tumor formation and progression. In addition, array CGH analyses on cDNA microarrays (13,000 clones) were carried out on 20 of the same patients. Classic CGH showed, on average, more aberrations in asbestos-exposed than in nonexposed patients, and an altered region in chromosome 2 seemed to occur more frequently in the asbestos-exposed patients. Array CGH revealed aberrations in 18 regions that were significantly associated with either of the two groups. The most significant regions were 2p21-p16.3, 5q35.3, 9q33.3-q34.11, 9q34.13-q34.3, 11p15.5, 14q11.2, and 19p13.1-p13.3 (P < 0.005). Furthermore, 11 fragile sites coincided with the 18 asbestos-associated regions (P = 0.08), which may imply preferentially caused DNA damage at these sites. Our findings are the first evidence, indicating that asbestos exposure may produce a specific DNA damage profile.
Similar articles
-
Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer.Oncogene. 2007 Jul 12;26(32):4730-7. doi: 10.1038/sj.onc.1210270. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297452
-
Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer.Clin Cancer Res. 2009 Jan 15;15(2):468-75. doi: 10.1158/1078-0432.CCR-08-1852. Clin Cancer Res. 2009. PMID: 19147751
-
Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.Lung Cancer. 2007 May;56(2):175-84. doi: 10.1016/j.lungcan.2006.12.010. Epub 2007 Jan 25. Lung Cancer. 2007. PMID: 17258348
-
Molecular and genetic changes in asbestos-related lung cancer.Cancer Lett. 2008 Jun 28;265(1):1-15. doi: 10.1016/j.canlet.2008.02.043. Epub 2008 Mar 24. Cancer Lett. 2008. PMID: 18364247 Review.
-
Chromosomal imbalances in human lung cancer.Oncogene. 2002 Oct 7;21(45):6877-83. doi: 10.1038/sj.onc.1205836. Oncogene. 2002. PMID: 12362270 Review.
Cited by
-
Arsenic, asbestos and radon: emerging players in lung tumorigenesis.Environ Health. 2012 Nov 22;11:89. doi: 10.1186/1476-069X-11-89. Environ Health. 2012. PMID: 23173984 Free PMC article. Review.
-
CGHpower: exploring sample size calculations for chromosomal copy number experiments.BMC Bioinformatics. 2010 Jun 17;11:331. doi: 10.1186/1471-2105-11-331. BMC Bioinformatics. 2010. PMID: 20565750 Free PMC article.
-
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.J Toxicol Environ Health B Crit Rev. 2011;14(1-4):76-121. doi: 10.1080/10937404.2011.556047. J Toxicol Environ Health B Crit Rev. 2011. PMID: 21534086 Free PMC article. Review.
-
Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.Mol Oncol. 2011 Oct;5(5):475-81. doi: 10.1016/j.molonc.2011.06.003. Epub 2011 Jul 12. Mol Oncol. 2011. PMID: 21802380 Free PMC article.
-
DNA Copy Number Variations as Markers of Mutagenic Impact.Int J Mol Sci. 2019 Sep 24;20(19):4723. doi: 10.3390/ijms20194723. Int J Mol Sci. 2019. PMID: 31554154 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical